LATERALIZED INTERDEPENDENCE BETWEEN LIMBICOTEMPORAL AND VENTROSTRIATAL DOPAMINERGIC TRANSMISSION

被引:42
作者
LOUILOT, A
LEMOAL, M
机构
[1] Laboratoire de Psychobiologie des Comportements Adaptatifs, INSERM U 259, Université de Bordeaux II, 33077 Bordeaux CEDEX, Domaine Carreire, Rue Camille Saint-Saens
关键词
D O I
10.1016/0306-4522(94)90171-6
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The antipsychotic effects of dopaminergic antagonists suggest dopaminergic hyperactivity plays a role in schizophrenia.4,6,23,29 However, an elevated number of D-2 dopamine receptors in the left putamen of nontreated schizophrenics has been reported12 which is consistent with a diminution of dopaminergic transmission in the ventral striatum. Morphological and functional studies have shown marked alterations in the left medial temporal lobe (entorhinal cortex, hippocampus, parahippocampus gyrus) of schizophrenics.3,7,8,10,11,34,35 As the entorhinal cortex and the ventral hippocampus project to the ventral striatum,14,18,30,33,36 the functional relationship between left temporal structures and the left ventral striatum may be impaired in schizophrenics. To assess the validity of this hypothesis, we investigated the existence of a preferentially left hemispheric interdependency between dopaminergic pathways in male rats. We found that dopaminergic projections in the entorhinal cortex and the ventral hippocampus regulate dopaminergic transmission in the nucleus accumbens, particularly in the left hemisphere. Temporal D-2 dopamine receptors seem to be primarily involved in this effect. This lateralized interdependent functioning appears structurally based. These results may provide new insights into the pathophysiology of schizophrenic psychoses.
引用
收藏
页码:495 / 500
页数:6
相关论文
共 36 条
[1]  
BAULAC M, 1986, REV NEUROL, V142, P85
[2]   LOCALIZATION OF DOPAMINE-D3 RECEPTOR MESSENGER-RNA IN THE RAT-BRAIN USING INSITU HYBRIDIZATION HISTOCHEMISTRY - COMPARISON WITH DOPAMINE-D2 RECEPTOR MESSENGER-RNA [J].
BOUTHENET, ML ;
SOUIL, E ;
MARTRES, MP ;
SOKOLOFF, P ;
GIROS, B ;
SCHWARTZ, JC .
BRAIN RESEARCH, 1991, 564 (02) :203-219
[3]  
BROWN R, 1986, ARCH GEN PSYCHIAT, V43, P36
[4]   ANTIPSYCHOTIC-DRUGS, NEUROTRANSMITTERS, AND SCHIZOPHRENIA [J].
CARLSSON, A .
AMERICAN JOURNAL OF PSYCHIATRY, 1978, 135 (02) :164-173
[5]  
CHARUCHINDA C, 1987, J NEUROSCI, V7, P1352
[6]   DOPAMINE RECEPTOR-BINDING PREDICTS CLINICAL AND PHARMACOLOGICAL POTENCIES OF ANTI-SCHIZOPHRENIC DRUGS [J].
CREESE, I ;
BURT, DR ;
SNYDER, SH .
SCIENCE, 1976, 192 (4238) :481-483
[7]  
CROW TJ, 1989, ARCH GEN PSYCHIAT, V46, P1145
[8]   LEFT GLOBUS-PALLIDUS ABNORMALITY IN NEVER-MEDICATED PATIENTS WITH SCHIZOPHRENIA [J].
EARLY, TS ;
REIMAN, EM ;
RAICHLE, ME ;
SPITZNAGEL, EL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (02) :561-563
[9]   CELL LOSS IN THE HIPPOCAMPUS OF SCHIZOPHRENICS [J].
FALKAI, P ;
BOGERTS, B .
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 1986, 236 (03) :154-161
[10]   LIMBIC PATHOLOGY IN SCHIZOPHRENIA - THE ENTORHINAL REGION - A MORPHOMETRIC STUDY [J].
FALKAI, P ;
BOGERTS, B ;
ROZUMEK, M .
BIOLOGICAL PSYCHIATRY, 1988, 24 (05) :515-521